Document is current
Any future updates will be listed below
-
Authors
Biechele, Gloria
Koliogiannis, Vanessa
Rennollet, Philippe
Prester, Tobias
Schulz, Enrico
Kolben, Thomas
Jegen, Magdalena
Hübener, Christoph
Hasbargen, Uwe
Flemmer, Andreas
Dietrich, Olaf
Burkard, Tanja
Schinner, Regina
Dinkel, Julien
Muenchhoff, Maximilian
Hintz, Susan
Delius, Maria
Mahner, Sven
Ricke, Jens
Hilgendorff, Anne
Stoecklein, Sophia https://orcid.org/0000-0003-0325-4674
-
Funding
Funding for this research was provided by:
Helmholtz Zentrum München (NWG VH-NG-829, NWG VH-NG-829, NWG VH-NG-829, NWG VH-NG-829)
German Center for Lung Research (BMBF)
Bayerisches Staatsministerium für Wissenschaft und Kunst (Corona Forschungsprogramm 2021/22)
Chan Zuckerberg Initiative
- License Information
-
More Information
Article History
Received: 23 February 2024
Revised: 28 May 2024
Accepted: 27 July 2024
First Online: 30 August 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Prof. Dr. S.S.
: O.D. is a member of the Scientific Editorial Board of European Radiology (section: Megnetic Resonance). They have not participated in the selection nor review processes for this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: Two authors have significant statistical expertize: Regina Schinner (Dipl. stat.) and Tanja Burkard (Master in Biostatistics).
: Only if the study is on human subjects: written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval (#LMU-207–33) was obtained.
: We published our finding of reduced fetal lung volume following mild maternal SARS-CoV-2 infection in the early, alpha-dominated phase of the pandemic as a Letter in The Lancet Respiratory Medicine in 2022 (). This prompted us to conduct a follow-up study in the late, omicron-dominated phase of the pandemic, with prevailing hybrid immunity. The non-COVID control group is identical in both studies. There is no overlap in the SARS-CoV-2 positive study cohorts.
:
